Two Sigma Advisers’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,485
| Closed | -$53.7K | – | 2714 |
|
|
2022
Q4 | $53.7K | Sell |
2,485
-7,340
| -75% | -$159K | ﹤0.01% | 2357 |
|
|
2022
Q3 | $240K | Sell |
9,825
-7,680
| -44% | -$188K | ﹤0.01% | 2145 |
|
|
2022
Q2 | $357K | Sell |
17,505
-9,560
| -35% | -$195K | ﹤0.01% | 2064 |
|
|
2022
Q1 | $964K | Sell |
27,065
-17,485
| -39% | -$623K | ﹤0.01% | 1656 |
|
|
2021
Q4 | $1.21M | Buy |
44,550
+29,055
| +188% | +$790K | ﹤0.01% | 1462 |
|
|
2021
Q3 | $672K | Sell |
15,495
-19,295
| -55% | -$837K | ﹤0.01% | 1796 |
|
|
2021
Q2 | $1.73M | Buy |
34,790
+4,625
| +15% | +$230K | ﹤0.01% | 1360 |
|
|
2021
Q1 | $1.36M | Buy |
30,165
+22,985
| +320% | +$1.03M | ﹤0.01% | 1477 |
|
|
2020
Q4 | $187K | Sell |
7,180
-210
| -3% | -$5.47K | ﹤0.01% | 2190 |
|
|
2020
Q3 | $106K | Buy |
+7,390
| New | +$106K | ﹤0.01% | 2268 |
|